At Roche we firmly believe that better patient care can be achieved through collaborative working with the NHS. The ABPI Code of Practice defines ‘Collaborative Working
with Organisations’ as work which either enhances patient care or is for the benefit of patients or alternatively benefits the NHS and, as a minimum, maintains patient care, and
must be carried out in a manner compatible with the Code.
Collaborative working is generally between one or more pharmaceutical companies, healthcare organisations and other organisations.
Joint working is a limited form of collaborative working and describes work between one or more Pharmaceutical companies and the NHS and others which is patient centred
and, the key defining point that separates it from collaborative working is that joint working always benefits patients.
Roche has successfully worked and continues to work alongside national, regional, and local NHS organisations to support and implement developments in healthcare delivery
for the benefits of patients.
Our collaborative working projects to date have aimed to:
- Improve quality throughout a patient's healthcare pathway
- Implement alternative models of care to increase patient access to care
- Support redesign of disease management services
- Better use of data to measure healthcare outcomes and reduce inequalities
- Enable NHS spending to translate into better healthcare outcomes
- Share good clinical practice across the NHS
All of this we believe can lead to patient benefits – access to quality healthcare services, and better healthcare outcomes. Roche UK has a number of roles that are able to deliver collaborative working projects with the NHS. The value of these roles and the time spent on specific projects is not factored into any Transfer of Value disclosures. Below is a list of collaborative working projects Roche is currently involved in. Click on the Executive Summary links below to learn more:
List of Collaborative Working projects Roche is currently involved in: